chrisvoncsefalvay/vaers-outcomes huggingface dataset:
started itching improved with benadryl , then minimal rash on legs , on exam it did not seem remarkable but after one week rash worsen to the point patient went to Emergency on  8/22/2022, then later to Urgent Care and had steroid injectable and steroid per mouth, saw dermatologist did biopsy showed vasculitis, was eventually referred to rheumatologist . Dermatologist believes this is a vaccination side effect. Rheuma has the booster vaccination  as a possible cause. this rash also was eventually associated to cough/difficulty breathing suspected bronchitis at the time, she had finished the steroids/antibiotic her cough is persistent. Work up still ongoing.
Unspecific Adverse event; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Unspecific Adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No specified medical history has been reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Unspecific Adverse event). At the time of the report, VACCINATION COMPLICATION (Unspecific Adverse event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment information was not provided.   Reporter did not allow further contact
Patient was administered 2nd dose of meningococcal vaccine early. Patient was not due until 16 years old for 2nd dose of meningococcal,  No reactions or treatment needed. Spoke to patients father patient had no symptoms after receiving vaccine.
High fever for three days up to 102F controlled with OTC medication. On the fourth day a rash appeared and lasted a day. On the fifth day the child's gums looked red and irritated and the child refused solid food. This lasted several days. The doctor diagnosed herpangina.
Information has been received from a healthcare worker concerning an 18 year old female with no pertinent medical history or allergies who on 12-SEP-2008 was vaccinated intramuscularly with a 0.5 mL fourth dose of GARDASIL (lot #661530/0575X). The dates of administration and the lot numbers for the previous 3 doses of GARDASIL were unknown. Concomitant therapy included influenza virus vaccine (unspecified). Subsequently the patient experienced arm pain, in an unspecified arm. The patient was seen at the office, no laboratory or diagnostics tests were performed. At the time of this report, the outcome was unknown. Additional information has been requested.
Within several hours of vaccination.  Patient came down with fever, chills and pain at injection site.  Went to emergency room 10/21- Febrile 102.2 degree F, tachycardic to 106.  Patient admitted 10/21.
74 yo woman living in a group home for people with developmental disabilities. She has longstanding difficult-to-control seizure disorder, on valproate, lamotrigine, and levetiracetam. She had asymptomatic COVID-19 infection in November 2020, probably discovered in the course of surveillance testing of residents/staff, perhaps in relation to an outbreak in the residence.  Sometime during the night following her vaccination earlier that morning, she developed a fever, and then was found to be having a generalized tonic-clonic seizure. Estimates of duration in the records range from 20 to 40 minutes. She was brought by ambulance to Hospital ED, and then admitted. Her temperature was said to be 103 F.  She received midazolam, and at least one dose of IV antibiotics. By the evening of admission on 5 February 2021, she was still unresponsive.  On arrival, her COVID-19 PCR was again/still positive. She had no prodromal symptoms suggesting COVID-19 reinfection, nor did anyone in the group home, staff or residents.  Her initial WBC was normal but with a slight left shift. UA was normal. Head CT showed her known cerebral atrophy and chronic microvascular disease.  Admitting valproate serum level was subtherapeutic; levatiracetam and lamotrigine levels were therapeutic.  Blood cultures are no growth at 2 days. Urine culture negative.  By hospital day 2, her transaminases had bumped to over 1000.
Pain in the left shoulder that has lasted for 6 weeks after immunization, is improving at this point.
Arm around injection site erythematous, swollen all the way to elbow. Flu like symptoms.
Discharge summary "Nursing home resident with dementia and recent stroke sent to ER with altered mental status and new COVID positivity.  ER evaluation noted obtundation and new rise in Cr to 7 from a prior of 1.  She was admitted and given IVF for what was presumed to be severe dehydration and possible ACE toxicity; urine culture was negative.  FENA was low suggestive of hypovolemia.  However, despite aggressive fluid replacement her Cr did not improve; her UA was positive for WBC and RBC but not WBC cast.  She required NC oxygen support.  Her sensorium returned to baseline but her Cr did not improve.  The possibility of COVID associated nephritis was considered and she was started on empiric decadron with prompt improvement of her renal function.  She was discharged home to her SNF for further care.  Creatinine improved to 3.7 at the time of discharge and she was making abundant urine.  ACE was stopped as it was unclear how much this contributed to her AKI.  Hydralazine was started for BP control."
4/23/2021 2nd Dose of Moderna Shot. Symptoms started at 9pm. Fever, body aches, chills, loss of appetite and nausea.  4/24/2021 Symptoms felt worse in the morning but got better through the day.   Body felt better at night  4/25/2021 No symptoms and regained appetite.
This case was reported by a physician and described the occurrence of maculopapular rash in a subject of unspecified age and gender who was vaccinated with TWINRIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of TWINRIX (unknown). Less than one day after vaccination with TWINRIX, the subject experienced maculopapular rash. At the time of reporting the event was unresolved. The physician considered the event was probably related to vaccination with TWINRIX.
Despite being fully vaccinated with 2-dose Pfizer vaccine, patient developed symptomatic Covid infection  At time of vaccine, patient experienced typical vaccine reactions (chills, fever, fatigue, myalgias, flu-like symptoms, as well as some numbness/tingling of arm immediately after first dose).  On 4/10/21, patient developed mild symptoms of Covid after a known exposure. Patient's symptoms include cough, congestion, headache.
headache, joint pain, muscle pain and spasms. pain similar to pinched nerve. Extreme tiredness, fever
Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 77-years-old female patient received bnt162b2 first dose of BNT162B2 (Pfizer-BioNTech COVID-19, Solution for injection, Batch/Lot number, NDC number, UPC number and Expiration date: unknown) via an unspecified route of administration on an unspecified date as 1st dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. After the first dose, patient had couple of days of fatigue. Patient asked about not having many side effects after getting the vaccine. Event recovered on an unspecified date.  Information about lot/batch number has been requested.
Lightheaded, dizzy, "seeing spots", sweaty, pale. Observed for 1 hr; oral fluids and food, discharged by physician.
I got pneumonia following my first dose of this vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PNEUMONIA (I got pneumonia following my first dose of this vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PNEUMONIA (I got pneumonia following my first dose of this vaccine) (seriousness criterion medically significant). At the time of the report, PNEUMONIA (I got pneumonia following my first dose of this vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided Treatment information was unknown.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding the event has been provided at this time. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
received first dose of shingrix on 23 july 2018, never got 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 23rd July 2018, batch number ZG47A, expiry date 12th February 2021).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The patient received 1st dose of Shingrix and did not receive 2nd dose, which led to incomplete course of vaccination. The patient never got 2nd dose. The reporter enquired to restart series or one dose should be given. The reporter consented to follow up.
Patient is 35 weeks pregnant and was recommended to get the RSV vaccine by her OB-Gyn. Patient received one dose of Arexvy's RSV vaccine. She should have received Abrysvo, which is approved for those under 60 years old.   Patient had no adverse reaction to the vaccine.
Pfizer-BioNTech COVID-19 Vaccine EUA  Approximately, 1 hr after receiving COVID-19 vaccine, noted general pruritus without rash, mild scleral injection. No other systemic symptoms.  Pt treated with Benadryl 25mg x1. Symptoms resolved within 30-45 minutes.
Pt was seen by physician. She had swelling on lips and face. This was worse in the morning (per nurse report) Vital signs were stable. Chest and lungs were clear. No breathing problems.
A little more than 24 hours following the vaccination, I developed Raynaud's, not having had it before.
the patient received incorrect medication, the patient received unauthorized Moderna COVID-19 vaccine / not age 12
Sunday April 11 at about 11pm I started feeling extremely drained of energy and was experiencing some mild abdominal pain. I went to bed shortly after. Was woken at approximately 5am with severe abdominal pain, and extreme back pain in my left kidney. Kidney area was worse than abdominal pain but both were severe. I have had kidney stones in the past, the pain of this was way worse. Was unable to take a bowel movement. Suffered thru with pain increasing until unspecified date at around 2 am I drove myself to unspecified hospital. Was admitted to emergency room and given an in mild pain meds and anti nausea meds. Was given a ct scan of kidney, then a second  ct scan with contrast, as well as blood test. After awhile they came back to re draw blood because they said my blood had clotted and they were unable to use it. I was released after 5 hours with no prescriptions or knowing what or why I was in so much pain.  Pain lasted until unspecified date
Confirmed no side effects or symptoms/No additional AE/no PQC; Pharmacist called to report an expired dose of PNEUMOVAX 23 was administered to a patient.; This spontaneous report was received from a pharmacist and refers to an unknown age patient.  The patient's concurrent conditions, medical history, drug allergies or reactions and concomitant therapies were not reported.  On 21-SEP-2023, the patient received an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 0.5 ml, lot #U032086 (which was confirmed to be a valid lot # for pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23)), expiration date reported and confirmed to be 29-AUG-2023 (route and site of administration, strength and indication not provided) (expired product administered). It was confirmed that there were no side effects or symptoms, no additional adverse event.
FATIGUE , HEADACHE,  I WOKE UP WITH A MIGRAINE . Mild headache for two days
Slight headache for several days following vaccine, resolved as of 12/28. On 12/28 she had a sudden wave of severe nausea, one episode of vomiting and subsequent generalized achiness with mild residual nausea.
upper body redness and rash vomiting diarhea dehydration (self administered liquid Benadryl and liquids after vomiting ended)
After my vaccine, I went to the hospital because I experienced  weakness some shortness of breath and some tremors. I am a doctor of training, one aspect the aspect of covid-19 affects testosterone.  I got Covid after my first dose.   I am still having some symptoms and scheduled to return back to work the third week of March 2021.
Erythema, redness, itching and discomfort (late onset) approximately 1 wk. RXN caused significant area of thigh.
Pt complained at ED of Headache, Nausea, SOB, felt like had been running. Pt in AFIB started on cardizem admitted to hospital 1/15 discharged 1/17
Hospitalized;  COVID-19 positive (9.1.21; 9.8.21);  fully vaccinated  Admission Date: 9/8/2021 Discharge Date:9/17/2021  Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute hypoxemic respiratory failure due to COVID-19 HOSPITAL COURSE: Patient is a 60M with past medical history of HTN, CLL ( not on treatment), OSA and fully vaccinated against COVID-19 who is presenting  with hypoxia and SOB. He tested positive for COVID 7 days ago (9/1) when he developed cough. He was scheduled to have monoclonial antibody infusion today however, was sent to the ED from the clinic due to hypoxia sats were at 87% prior to the infusion.He reports cough, chest heaviness, diarrhea and fevers. He has since been having worsening dyspnea, productive cough and persistent fever and chills. . He was febrile tachycardic and hypoxic on admission. He was placed on 2L oxygen with improvement in his oxygenation. Labs were notable for CRP 340.2, WBC 33.45, hgb 10.9.  He was admitted for acute hypoxic respiratory failure related to COVID-19 infection and possible superimposed bacterial pneumonia.  CT angiogram thorax showing no evidence of pulmonary embolism.  He received 5 days of remdesivir, and 10 days of Decadron.  He was noted to have elevated procalcitonin.  Blood and sputum cultures were negative.  He was placed on Rocephin and doxycycline for 7 days. He has had worsening respiratory status requiring placement of a HFNC. He was seen by pulmonary medicine. Inflammatory markers trended down. For his CLL he was diagnosed April 2021 with baseline WBC of 20. He is currently on not on active treatment. WBC level increased in the setting of infection and decadron use 9/17/2021 Pt S+E. Now on room air and stable at discharge. Patient in agreement with verbal instructions to return to ED if he experiences increased SOB. He will follow with his outpatient physicians
Fever of 101F, severe body ache, chills and nausea after 12 hrs of receiving vax
urticaria, facial swelling, and cough 2 hours after vaccine.  No injection site swelling.  parent took patient Hospital ER.
About 45 minutes to an hour after the administration of the vaccine m, my cheeks became red, hot, and swollen. There were also hives. I took Benadryl which stopped the spreading but it did not go away. I had shortness of breath, and by about 6:00 it was hard to breath when lying down. I did an albuterol treatment with my nebulizer. It helped but it took much longer than usual. There were was about 30 minutes that I found my epipen and was going to the ED if it got worse.  My breathing improved. The red changed to pink but was still swollen and tight 7 hours later. The second one of Benadryl helped get rid of most of the pinkness. When I woke up this morning, I had a little bit of a wheezy cough that I didn?t have yesterday.  My daily Zyrtec and singular helped that a little. I have new hives along my jawline this morning that are very minor but they do itch. The redness and swelling was similar to reactions I?ve gotten when I drink a beer or have eaten soft shell crab, but typically Benadryl will clear that up and it doesn?t linger for so long.  This was more aggressive. My side effects at this point are minor, but I have a call in to my allergist to see if I should be doing anything different and questions about the second dose.
This spontaneous case reported by a consumer (subsequently medically confirmed), describes the occurrence of arthralgia (excruciating joint pains: wrists and hips) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# unknown) for COVID-19 immunization. No medical history reported. On Feb 22, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Feb 26, 2021, patient experienced arthralgia (excruciating joint pains: wrists and hips). The patient treated with Advil (ibuprofen), at an unspecified dose and frequency. At the time of the report, arthralgia (excruciating joint pains: wrists and hips): resolving. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications reported. Treatment of the events included ibuprofen.
Woke up day after receiving H1N1 vaccine with rash on arms and back which progressed to stomach and lower legs (see attached).
Headache; Sore muscle at injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 62-year-old adult male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via unspecified route of administration on the left arm on 17Mar2021 at 11:30 (at the age of 62years) as a single dose for COVID-19 immunisation. Medical history included atrial fibrillation and blockage, major depression, posttraumatic stress disorder (PTSD), sleep apnea, tinnitus. The patient did not have any allergies to medications, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested positive for COVID-19. The patient did not receive any other medications within 2 weeks of vaccination. Concomitant medication was not reported. On 17Mar2021, the patient experienced "sore muscle at injection site. Started developing a headache around 3pm, continued worsening. Around 8am it began to subside. Around 9 it was gone". The clinical outcome of the events sore muscle at injection site and headache was recovered.   No follow-up attempts are needed. No further information is expected.
030- C/O DIZZINESS A  LITLE LA FRONTL; DENIES CP OR PRESSURE, NO BLURRED VISION. HEADACH:CONSTANT, NON THROBBING, LOCALIZED TO FRONTAL REGION  PTS DAUGHTER ADVISED TO PROVID HTN MEDS AND FOOD/HYDRATION ONCE BP LOWERS, PATIENT SENT HOME
Cellulitis upper left deltoid 10x6cm. Tx: Augmentin ES 600 1 1/2 po bid x 10 days. Motrin 200mg q 6h prn.
suspected vaccination failure/got the vaccine and got them twice; got the vaccine and got them twice; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details provided were as follows: The case was reported by wife of the patient. Age at vaccination was not reported. The patient received a dose of Shingles vaccine and experienced Shingles twice. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow-up would not be possible as no contact details available.
Pfizer-BioNTech COVID-19 Vaccine EUA: two weeks after vaccination patient hospitalized with COVID-19 infection. Patient received increased oxygen from home baseline requirements, remdesivir, and dexamethasone and discharged to home medically stable.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions and allergies were not reported. ON 19-JUN-2015, the patient was vaccinated with VARIVAX (Merck) (lot#L001327, expiration date: 13-JAN-2017; dose, route of administration and anatomical location were not reported) that was improperly stored. No adverse events were reported. This is one of several reports received from the same source. Additional information has been requested.
After recieving the shot the patient started to pass out, his dad grabbed him and lowered him to the ground.  He then got up with help and sat in a chair for 10 minutes before leaving on his own.
I'm experiencing dizziness from time to time that I have experienced before the vaccination.; This is a spontaneous report from a contactable consumer (patient). A 55-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number=EL3249), on 23Jan2021 09:45 at SINGLE DOSE in Left arm for covid-19 immunisation.  Facility where the most recent COVID-19 vaccine was administered was Doctor's office/urgent care. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included anxiety, dizziness.  Concomitant medication received within 2 weeks of vaccination included vortioxetine hydrobromide (TRINTELLIX), naproxen sodium (ALEVE), fluticasone propionate (FLONASE), ascorbic acid, betacarotene, biotin, calcium, chromium, colecalciferol, copper, folic acid, iodine, iron, lycopene, magnesium, manganese, nicotinamide, pantothenic acid, phosphorus, phytomenadione, potassium, pyridoxine hydrochloride, retinol, riboflavin, selenium, vitamin b1 nos, vitamin b12 nos, vitamin e nos, xantofyl, zinc (CENTRUM SILVER).  The patient experiencing dizziness from time to time on 23Jan2021 03:00 PM that he has experienced before the vaccination. The outcome was Not recovered. No treatment received for the adverse event. The event was assessed non-serious. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.
Estimated due date was 4-21-18. On 9-8-17, I went in the office for my first prenatal check up and received the flu vaccine. Ultrasound showed that baby was measuring at 7 weeks 2 days. On 9-30-17, my body recognized that something was not right. After getting another ultrasound in the ER on 9-30-17, the baby was only measuring at 7 weeks 5 days (approximate date of death would be 9-12-17), when in fact it should have been measuring around 11 weeks.
Patient had notable arm pain, erythema, and a fever of 101F by the following day of the vaccine. The reactions began to subside over the next couple of days. The only significant adverse reaction that remains is a hard lump about the size of a golf ball at the site of injection.
Bicepital tendonitis diagnosis code M75.21. Biceps Tenosynovitis diagnosis code 726.12. Impingent syndrome M75.41. Received cortisone, physical therapy.